Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025 is an in-depth CME course led by renowned faculty from Harvard Medical School (HMS) and select distinguished guest speakers. This program offers a comprehensive and up-to-date review of gastrointestinal, liver, and pancreatic pathology, with a particular focus on:
- New disease entities and recent advances in diagnostic surgical pathology that are highly relevant to current practice.
- A systematic approach to evaluating biopsy and resection specimens—from gross examination to microscopic assessment—integrated with the appropriate use of ancillary techniques such as immunohistochemistry and molecular diagnostics.
- Clinical application and practice-oriented learning, equipping participants with tools to improve diagnostic precision and patient outcomes through better use of biomarkers and emerging strategies.
* Date of Original Release: May 12-14, 2025
LEARNING OBJECTIVES
Upon completion of this activity, participants will be able to:
- Discuss updates in the new WHO classification of tumors of the digestive system.
- Identify newly described entities in the differential diagnosis of inflammatory disorders of the GI tract.
- Evaluate morphological criteria and role of ancillary techniques (immunohistochemistry and molecular methods) in diagnosis of pre-neoplastic lesions of the GI tract.
- Use screening methods for heritable cancers and standard of care biomarkers currently used for targeted therapy.
- Recognize nuances of interpretation of morphological patterns in liver biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
- Recognize proper application and limitations of disease staging and grading systems.
- Recognize common and uncommon hepatic tumors.
- Recognize nuances of interpretation of morphological patterns in pancreatic biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
- Describe the spectrum of benign and neoplastic pancreatic disorders with emphasis on use of proper nomenclature and reporting findings of prognostic significance.
HARVARD GASTROINTESTINAL, LIVER, AND PANCREATIC PATHOLOGY 2025